Literature DB >> 4631868

Anti-C3a, anti-C3B (anti-B) and their reaction with the anaphylatoxic fragment C3a.

J L Molenaar, A ten Velde, K W Pondman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4631868

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  8 in total

1.  Inhibition of neutrophil function by fluid phase C3b of complement.

Authors:  J D Ogle; C K Ogle; J W Alexander
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

2.  Burn wound sepsis may be promoted by a failure of local antibacterial host defenses.

Authors:  E A Deitch; R M Bridges; M Dobke; J C McDonald
Journal:  Ann Surg       Date:  1987-09       Impact factor: 12.969

3.  Immunological studies of human placentae: identification and distribution of proteins in mature chorionic villi.

Authors:  W P Faulk; P M Johnson
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

4.  Consumptive opsoninopathy: possible pathogenesis in lethal and opportunistic infections.

Authors:  J W Alexander; M A McClellan; C K Ogle; J D Ogle
Journal:  Ann Surg       Date:  1976-12       Impact factor: 12.969

5.  Three rat monoclonal antibodies to human C3.

Authors:  P J Lachmann; R G Oldroyd; C Milstein; B W Wright
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

6.  A sequential, prospective analysis of immunologic abnormalities and infection following severe thermal injury.

Authors:  J W Alexander; C K Ogle; J D Stinnett; B G Macmillan
Journal:  Ann Surg       Date:  1978-12       Impact factor: 12.969

7.  Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.

Authors:  M T Aguado; J D Lambris; G C Tsokos; R Burger; D Bitter-Suermann; J D Tamerius; F J Dixon; A N Theofilopoulos
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

8.  Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.

Authors:  P J Lachmann; M K Pangburn; R G Oldroyd
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.